ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.0% | -34.8% | +46.5% | -5.8% | +4.5% | -0.5% | +1.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | -3.1% | -36.2% | -32.4% | +5.8% | -33.0% | -46.5% | -59.2% | +76.1% | +84.7% | +71.2% | |
| – | – | – | – | – | – | – | – | – | -3.9% | +212.3% | -24.6% | |
| – | -5.9% | -5.5% | -31.6% | -15.9% | -9.5% | -25.3% | -12.8% | -64.6% | +29.5% | +139.9% | +17.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11.4% | +17.6% | +2.9% | +18.8% | -16.5% | -52.6% | +2.2% | +105.5% | -36.2% | -90.6% | -72.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.